Plus Therapeutics (PSTV) Cash from Operations Growth (3y) (2013 - 2026)
Plus Therapeutics (PSTV) Cash from Operations Growth (3y) (2013 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Cash from Ops. Growth (3y) (Qtr) |
| 1 |
Alterity Therapeutics |
788,338.31 Bn |
788,338.28 Bn |
- |
- |
| 2 |
Belite Bio |
56,560.00 Bn |
56,560.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,329.30 Bn |
17,329.30 Bn |
- |
- |
| 4 |
Legend Biotech |
3,341.00 Bn |
3,340.71 Bn |
242.10 Mn |
37.40% |
| 5 |
Akari Therapeutics |
1,727.91 Bn |
1,727.91 Bn |
- |
20.11% |
| 6 |
Evaxion A |
1,536.68 Bn |
1,536.67 Bn |
- |
- |
| 7 |
Psyence Biomedical |
238.34 Bn |
238.33 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
113.42 Bn |
106.17 Bn |
2.59 Bn |
16.64% |
| 9 |
Abivax |
95.45 Bn |
95.45 Bn |
- |
- |
| 10 |
Plus Therapeutics |
34.26 Mn |
19.15 Mn |
- |
-2.50% |
| Date | Value |
|---|
| Mar 31, 2026 |
-2.50% |
| Dec 31, 2025 |
-41.09% |
| Sep 30, 2025 |
15.69% |
| Jun 30, 2025 |
-29.98% |
| Mar 31, 2025 |
-16.77% |
| Dec 31, 2024 |
22.72% |
| Sep 30, 2024 |
-17.80% |
| Jun 30, 2024 |
21.74% |
| Mar 31, 2024 |
-14.51% |
| Dec 31, 2023 |
16.44% |
| Sep 30, 2023 |
-1.43% |
| Jun 30, 2023 |
-25.39% |
| Mar 31, 2023 |
-56.82% |
| Dec 31, 2022 |
-60.78% |
| Sep 30, 2022 |
-18.74% |
| Jun 30, 2022 |
-31.92% |
| Mar 31, 2022 |
-5.83% |
| Dec 31, 2021 |
-1.79% |
| Sep 30, 2021 |
5.26% |
| Jun 30, 2021 |
4.11% |
